Application of AAV2-mediated bFGF gene therapy on survival of ischemic flaps: effects of timing of gene transfer

Annals of Plastic Surgery
Paul Y LiuJin Bo Tang

Abstract

Necrosis of surgically transferred flaps is a major problem in reconstructive surgery. We investigated efficacy of a new vector system-adeno-associated viral 2 (AAV2)-mediated bFGF gene transfer to enhance survival of the ischemic flap. Thirty-eight Sprague-Dawley rats were divided into 3 gene therapy groups and 1 nontreated control of 9 or 10 each. 7.5 x 10(10) AAV2-bFGF viral particles were injected to the dorsum of each of the 29 rats; these rats were divided into 3 groups according to the timing of flap elevation. At the time of surgery, 1 week, and 2 weeks after surgery, flaps of 3 x 7 cm were raised. One week after surgery, flap viability was measured. Vascularization and immunohistochemical staining of the bFGF were evaluated of histologic sections. Flap viability was significantly improved by the AAV2-bFGF gene therapy at the time of surgery, and the flaps with the greatest survival area were found in the rats injected with AAV2-bFGF, 2 weeks before surgery. However, flap viability was significantly decreased by the gene therapy 1 week before surgery. Histologically, vascularity was increased in the groups with AAV2-bFGF injection and immunohistochemical staining showed greatly enhanced bFGF expression by gene transfer....Continue Reading

References

Mar 1, 1992·Annals of Plastic Surgery·M J ImA Fenselau
Oct 1, 1995·Plastic and Reconstructive Surgery·E A AbbaseM H el-Falaky
Sep 1, 1993·Journal of Reconstructive Microsurgery·Y KomuroY Yonehara
Feb 1, 1996·Archives of Otolaryngology--head & Neck Surgery·A V NallA Kalra
Sep 29, 1999·Journal of Medical Virology·K ErlesJ R Schlehofer
Mar 30, 2000·The Journal of Gene Medicine·B A DonahueR O Snyder
Sep 14, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·U R Hengge, A Mirmohammadsadegh
Oct 20, 2000·Clinical Orthopaedics and Related Research·E M Schwarz
Apr 24, 2001·Journal of Reconstructive Microsurgery·M J HawsR C Russell
Jul 20, 2001·Annals of the New York Academy of Sciences·V W van HinsberghP Koolwijk
Jan 11, 2002·British Journal of Plastic Surgery·G O'TooleM Poole
May 8, 2002·Plastic and Reconstructive Surgery·Przemyslaw LubiatowskiMaria Siemionow
May 18, 2005·British Journal of Plastic Surgery·Y FujiharaT Takato
Jun 23, 2005·Journal of Reconstructive Microsurgery·Paul Y LiuIan Summerhayes
Dec 20, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Roy M BremnesRafael Sirera
Apr 25, 2006·Journal of Endodontics·Ivan MoldauerSergio Kuttler
Sep 29, 2007·Annals of Plastic Surgery·Christina RollBernd Kinner
Oct 24, 2007·The Journal of Hand Surgery, European Volume·R G XieJ B Tang

❮ Previous
Next ❯

Citations

Jun 9, 2011·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Xiao Tian WangPaul Y Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.